Success Metrics

Clinical Success Rate
96.3%

Based on 26 completed trials

Completion Rate
96%(26/27)
Active Trials
1(2%)
Results Posted
27%(7 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_3
2
4%
Ph not_applicable
13
28%
Ph phase_2
1
2%
Ph phase_4
25
54%
Ph early_phase_1
1
2%

Phase Distribution

1

Early Stage

1

Mid Stage

27

Late Stage

Phase Distribution42 total trials
Early Phase 1First-in-human
1(2.4%)
Phase 2Efficacy & side effects
1(2.4%)
Phase 3Large-scale testing
2(4.8%)
Phase 4Post-market surveillance
25(59.5%)
N/ANon-phased studies
13(31.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.7%

26 of 30 finished

Non-Completion Rate

13.3%

4 ended early

Currently Active

1

trials recruiting

Total Trials

46

all time

Status Distribution
Active(3)
Completed(26)
Terminated(4)
Other(13)

Detailed Status

Completed26
unknown13
Withdrawn3
Recruiting1
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
46
Active
1
Success Rate
96.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.4%)
Phase 21 (2.4%)
Phase 32 (4.8%)
Phase 425 (59.5%)
N/A13 (31.0%)

Trials by Status

unknown1328%
recruiting12%
completed2657%
enrolling_by_invitation12%
terminated12%
withdrawn37%
not_yet_recruiting12%

Recent Activity

Clinical Trials (46)

Showing 20 of 46 trialsScroll for more
NCT04291521

Prospective Study of Induction Medications Used in the Trauma RSI

Withdrawn
NCT05277896Phase 4

Randomized Trial of Sedative Choice for Intubation

Completed
NCT06179485

Effect of Ketamine and Etomidate During RSI on Long Term Outcomes

Enrolling By Invitation
NCT07012902Early Phase 1

Relationship Between Remimazolam and Etomidate in Induction of General Anesthesia

Not Yet Recruiting
NCT06664138Phase 4

Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment

Completed
NCT05223907Phase 4

Safety and Efficacy of Maintenance of Etomidate in General Anesthesia

Completed
NCT05748665Not Applicable

Effect of Remimazolam on the Recovery Quality After Day Surgery

Completed
NCT06068764Phase 4

Etomidate Versus Propofol in CABG Surgery

Recruiting
NCT02453373Not Applicable

Helping Stroke Patients With ThermoSuit Cooling

Terminated
NCT02822144Phase 3

General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke

Completed
NCT03852797Not Applicable

Spontaneous and Oxytocin-induced Contractility After Exposure to Intravenous Anesthetic Agents: an In-vitro Study in Human Myometrium

Completed
NCT05520645Not Applicable

Etomidate Induction in Hysteroscopic Surgery

Unknown
NCT02643381Phase 4

Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial

Completed
NCT03545503Phase 4

Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation

Completed
NCT04865614

Comparison Between Inhalation and Intravenous Induction of Anaesthesia During Interventional Mitral Valve Repair

Completed
NCT04934410

Induction Agent and Incidence of Hypotension in Heart Failure Patients Undergoing LVAD-Implantation

Unknown
NCT04857450Not Applicable

Anesthesia for Upper Endoscopy and Colonoscopy in Cardiac Patients With Acute Anemia

Unknown
NCT02910206Not Applicable

Etomidate to Improve Outcome in Elderly Patients

Completed
NCT02105415Phase 2

Ketamine / Propofol Admixture "Ketofol" at Induction in the Critically Ill Against Etomidate: KEEP PACE Trial

Completed
NCT01823328Phase 4

Ketamine Versus Etomidate for Rapid Sequence Intubation

Completed

Drug Details

Intervention Type
DRUG
Total Trials
46